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Abstract
Purpose: To assess the utility of brain parenchyma density measurement on unenhanced computed tomography (CT) 
in predicting brain death (BD), in order to evaluate the added value of CT perfusion (CTP).
Material and methods: A total of 77 patients who were clinically diagnosed as BD and had both CT angiography (CTA) 
and CTP imaging in the same session were retrospectively reviewed. On unenhanced phase of CTA, density measu­
rement was performed from 23 regions of interests (ROIs) which were located in the following areas: level of basal 
ganglia (caudate nucleus, putamen, corpus callosum, posterior limb of internal capsule), level of brainstem, grey­ 
white matters on levels of centrum semiovale (CS), high convexity (HC), and cerebellum. CTP images were evaluated 
qualitatively and independently. Grey matter (GM), white matter (WM), density, and GM/WM density ratio of BD 
patients were compared with control subjects.
Results: Comparing with the normal control group, the GM and WM density at each level and GM/WM density ratio 
of CS, HC, and cerebellum level were significantly lower in brain­dead patients (p = 0.019 for HC­WM, p < 0.001 for 
other areas). Using ROC analysis, the highest value of area under curve (AUC) for the GM/WM density ratio was found 
at the HC level (AUC = 0.907). The sensitivity of the GM/WM density ratio at the HC level was found to be 90% when 
the cut­off value of 1.25 was identified. Evaluating the GM/WM density ratio together with the CTP results increased 
the sensitivity further to 98%.
Conclusions: The GM/WM density ratio at the HC level on unenhanced CT may be a useful finding to predict BD. 
Also, the addition of CTP increases the sensitivity of this method. 
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Introduction
The algorithm of brain death (BD) diagnosis occurs on 
the basis of clinical findings and neurological examination, 
which is followed by ancillary tests, especially when con­
founding factors (e.g. metabolic and endocrine disturbanc­
es, sedative drugs) could affect the clinical evaluation [1]. 
Computed tomography angiography (CTA) has been ac­
cepted as one of the ancillary tests and is commonly used 
for the confirmation of cerebral circulatory arrest in BD [2]. 
In addition, computed tomography perfusion (CTP) is 
known to be a highly sensitive method in the diagnosis of 
BD by showing the lack of cerebral perfusion [2­4].
Unenhanced CT findings of BD have been previously 
described as diffuse cerebral oedema, loss of distinction 
between grey matter (GM) and white matter (WM), and 
herniation [5]. Cerebral oedema occurs as a result of in­
crease in water content of GM and is mainly responsible for 
the reduction of attenuation in the cerebral cortex on CT 
imaging [6­8]. In two studies conducted by Inamasu et al., 
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the role of loss of GM­WM discrimination in predicting 
the prognosis after cardiac arrest was investigated, and it 
was shown that this sign could be related to poor outcome 
[9,10]. In addition, there are various studies evaluating the 
prognostic value of the GM/WM ratio as a quantitative 
method in comatose patients after cardiac arrest [11­17]. 
According to the American Heart Association guidelines 
for post­cardiac arrest care, the presence of a significant 
decrease of GM/WM ratio could be used as a predictor of 
poor outcome in patients with coma, who are not treated 
with hypothermia [18].
In routine clinical practice, comatose patients are 
evaluated cautiously for signs of BD. Nevertheless, it is 
also critical to have a reliable and accurate method that 
could predict BD in such patients at early stages, espe­
cially for organ donation. For this reason, a few studies 
have shown the relationship between BD and GM­WM 
density changes [19,20]. However, a study that evaluated 
unenhanced CT and CTP for the prediction of BD has not 
been reported, to our knowledge. In this study, we aimed 
to evaluate the effectiveness of density measurement from 
various regions on unenhanced CT scan and the contribu­
tion of CTP in predicting BD.
Material and methods
Study population
The study protocol was approved by our institutional re­
view board. Written informed consent was waived due to the 
retrospective nature of this study. Between September 2014 
and July 2018, 92 patients who underwent CT after clinical 
diagnosis of BD were collected from our database. Inclusion 
criteria were patients with clinically diagnosed BD and who 
had CTA and CTP obtained with BD protocol. After the ex­
clusion of nine patients without CTP images, five patients 
with unenhanced CT images that were unsuitable for den­
sity measurement due to the artifacts, and one patient with 
an extensive extracalvarial herniation after decompres­
sive craniectomy, 77 patients were enrolled in the study. 
The control group was retrospectively collected from the 
PACS database, including age­ and sex­matched patients who 
had an unenhanced CT scan without evidence of ischaemia, 
intracranial haemorrhage, neoplastic lesion, or parenchymal 
disease. A flow chart of the study is shown in Figure 1.
Computed tomography protocol and density 
measurements on unenhanced computed tomography
All CT examinations were acquired with a 128­detec­
tor (Siemens Somatom Definition AS, Munich, Germany) 
or 64­detector (Toshiba Aquilion, Tokio, Japan) CT scan­
ner (64 vs. 13 patients, respectively). The acquisition pa­
rameters were slice thickness of 1 mm, pitch 0.55, 100 kV, 
200 mAs, 220 FOV, and 512 × 512 matrix in our routine 
BD protocol. Despite the fact that this protocol includes 
two­phase CTA (arterial phase scan at the 20th and venous 
phase scan at the 60th second after contrast administra­
tion), only unenhanced scans were evaluated in this study. 
CT scans were performed within 2­12 hours of clinical 
examination of BD. In the control group, unenhanced CT 
images were obtained with standard head CT protocol with 
a slice thickness of 5 mm at either 128­detector or 64­detec­
tor CT scanner (67 vs. 10 subjects, respectively). All den­
sity measurements of the patient group were performed by 
two radiologists (H.S. and A.A.) independently, who were 
blinded to measurements of each other. The measurements 
of the senior radiologist (H.S.) with 10 years of experience 
in the assessment of CTA for BD confirmation were ac­
cepted as the reference standard. CT images of the control 
group were measured by the other radiologist (A.A.). 
Circular region of interests (ROIs) were placed in sev­
eral areas in brain parenchyma, which were first described 
by Torbey et al. [11] and modified by Vigneron et al. [19]. 
In this study, two different places were added, and Houn­
sfield unit (HU) measurements were taken from each of 
23 ROI in the following areas (Figure 2): 
•	 Level of basal ganglia (BG): caudate nucleus (CN), puta­
men (PU), corpus callosum (CC), and posterior limb of 
internal capsule (PIC) were included. The GM to WM 
ratio was calculated according to the following method, 
which was described in previous studies [8,12­14]:
    GW/WM density ratio (BG) = (CN + PU)/(CC + PIC).
•	 Level of centrum semiovale (CS): GM and WM of each 
hemisphere were measured 5 mm above the level of BG 
and average values of HU were calculated.
•	 Level of high cerebral convexity (HC): GM and WM of 
each hemisphere were measured 5 mm above from level 
Comparison of patient and control group  
for density measurements 
Patients with clinical 
diagnosis of brain death 
with CTA/CTP  
(n = 92)
Patients with unenhanced CT 
and CTP available for analysis 
(n = 77) 
Evaluation of CTP images Density measurements 
from GM and WM 
Calculation of  
GM/WM ratio
Density measurements 
from GM and WM 
Calculation of  
GM/WM ratio
Sex and age matched control 
subjects with normal findings 
on unenhanced head CT  
(n = 77) 
Excluded (n = 15) 
-  No CTP images (n = 9) 
-  Artifacts, remarkable hemorrhage (n = 5) 
-  Extensive extracalvarial herniation (n = 1) 
Patient group Control group
Figure 1. Study flowchart
CTA – computed tomography angiography, CTP – computed tomography perfusion, WM –  white 
matter, GM – grey matter
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of CS and averaged. ROIs were placed to medial parts 
of the brain parenchyma in order not to be affected by 
beam hardening artifact on both HC and CS levels.
•	 Level of cerebellum: GM and WM of each hemisphere 
were measured and averaged.
•	 Level of brain stem (BS): midbrain, pons, and medulla 
oblongata were measured from the middle part with 
an ROI cursor of 20 mm2 differently from other levels, 
which were calculated with 10 mm2 circular ROI.
In both patient and control groups, the mean HU values 
of WM, GM, and GM/WM density ratio were recorded at 
each level. However, regions that could not be evaluated 
due to the remarkable haemorrhage, infarct, shift, or arti­
facts were not included in the analysis in the patient group.
Computed tomography perfusion protocol  
and interpretation
CTP images were obtained with a bolus of contrast me­
dia (40 ml) 10 minutes after CTA in our routine BD pro­
tocol. CTP scan was performed between the level of inter­
nal carotid artery bifurcation and superior edge of lateral 
ventricles with a section thickness of 10 mm and a total 
scan time of 45 seconds. ROIs were placed automatically 
at the anterior cerebral artery for arterial input and supe­
rior sagittal sinus for venous outflow. Cerebral blood flow 
(CBF), cerebral blood volume (CBV), and mean transit 
time (MTT) maps were acquired by automatic calculation. 
All images were assessed independently by two radiolo­
gists (H.S. and Y.P.) with five years of experience in the 
evaluation of CTP for BD confirmation. Final decision was 
made by a consensus if there was a conflict in the results. 
Readers were blinded to the clinical examination and pre­
vious radiological reports in terms of BD diagnosis. CBV 
and CBF maps were evaluated qualitatively, and complete 
absence of perfusion in the cerebral parenchyma was ac­
cepted as cerebral circulatory arrest.
Statistical analysis
Statistical analysis was made using SPSS software ver­
sion 21.0 (IBM). The Mann­Whitney U test was used to 
compare GM and WM density and the GM/WM density 
ratio of BD patients with the normal control group. Re­
ceiver operating characteristic (ROC) curves were ana­
lysed to identify the cut­off value of the GM/WM den­
sity ratio for the prediction of BD as well as calculating 
the sensitivity and specificity. Inter­rater variability was 
evaluated by using interclass correlation coefficient (ICC). 
r values including the range from 0 to 1.00 were described 
as follows: < 0.40, poor; 0.41­0.60, moderate; 0.61­0.80, 
good; ≥ 0.81, excellent agreement. A p value of less than 
0.05 was considered statistically significant.
Results
Seventy­seven patients clinically diagnosed as BD 
(36 fe male, 41 male; mean age, 43.84 ± 23.25 years; range 
0­80 years) and 77 age­ and sex­matched control subjects 
(36 female, 41 male; mean age, 43.92 ± 23.07 years; range 
Figure 2. Brain computed tomography images of a normal patient showing the regions where ROI’s are placed for the density measurement. From the top 
left-to the bottom right corner: level of basal ganglia, centrum semiovale, high convexity, midbrain, pons and cerebellum, medulla oblongata, respectively
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0­83 years) were included in the study. The initial causes 
of coma were intracranial haemorrhage (n = 36, 46.7%), 
high­energy trauma (n = 11, 14.2%), cardiac arrest (n = 10, 
12.9%), postoperative clinical conditions (n = 8, 10.3%), 
intoxication (n = 6, 7.7%), ischaemic stroke (n = 3, 3.8%), 
infection (n = 2, 2.5%), and asphyxia (n = 1, 1.2%).  
In a comparison between the patient and control groups, 
WM and GM densities at the level of BG (caudate nucleus, 
putamen, corpus callosum, and posterior limb of internal 
capsule), CS, HC, BS (midbrain, pons, and medulla oblon­
gata), and cerebellum were significantly lower in BD patients 
(p = 0.019 for HC­WM, p < 0.001 for other areas). The GM/
WM density ratio of CS, HC, and cerebellum were found to 
be significantly lower in BD patients (p < 0.001 for all levels), 
but there was no difference of GM/WM density ratio at the 
level of BG between the two groups (p = 0.069) (Table 1).
ROC analysis of the GM/WM density ratio for pre­
dicting BD showed that the highest value of area under 
curve (AUC) was found to be 0.907 at the level of HC 
(AUC = 0.907, CI: 0.858­0.956). AUC values of CS, BG, 
and cerebellum level were identified as 0.837, 0.585, and 
0.670, respectively (Figure 3). When a cut­off value of 
GM/WM density ratio at HC level was determined as 
1.25, sensitivity and specificity values in predicting BD 
were 90% and 73%, respectively.
When CTP was assessed alone in patients with BD, 
72/77 patients were interpreted as BD with sensitivity of 
93%. The addition of CTP to the evaluation of the GM/
WM density ratio of the HC level increased the sensitivity 
in predicting BD to 98% (Figure 4).
Inter­rater agreement of the radiologists in evaluating 
the density measurement of GM and WM from specified 
regions was found to be excellent at the level of BG for 
both GM and WM (r = 0.869 and 0.817, respectively); at 
the level of CS WM (r = 0.894) and the level of HC WM 
(r = 0.830). The lowest agreement was detected at the level 
of cerebellum WM, which was moderate (r = 0.522). All 
values for each level are shown in Table 2.
Discussion
In our study, the value of density measurement and 
the GM/WM density ratio in predicting BD were evaluat­
ed, and the GM­WM densities of each of 23 areas and the 
Table I. Comparison of density values and ratio at each level between the patient and control groups
Level Patient group Control group p-value
Basal ganglia
BG grey matter 32.08 ± 4.27 42.05 ± 5.79 < 0.001
Caudate nucleus 31.46 ± 4.59 43.26 ± 6.90 < 0.001
Putamen 32.70 ± 4.60 40.84 ± 5.18 < 0.001
BG white matter 27.29 ± 3.11 35.26 ± 6.47 < 0.001
Corpus callosum 27.30 ± 3.32 36.09 ± 7.34 < 0.001
Posterior limb of internal capsule 27.28 ± 3.71 34.42 ± 6.21 < 0.001
GM/WM density ratio 1.17 ± 0.12 1.20 ± 0.11 0.069
Centrum semiovale
Grey matter 33.26 ± 4.89 46.82 ± 9.17 < 0.001
White matter 29.33 ± 3.84 35.37 ± 7.36 < 0.001
GM/WM density ratio 1.13 ± 0.14 1.33 ± 0.14 < 0.001
High convexity
Grey matter 35.67 ± 5.24 47.60 ± 9.82 < 0.001
White matter 32.60 ± 4.63 36.22 ± 8.21 0.019
GM/WM density ratio 1.09 ± 0.11 1.32 ± 0.12 < 0.001
Cerebellum
Grey matter 39.76 ± 7.57 49.98 ± 9.15 < 0.001
White matter 32.09 ± 5.28 37.01 ± 7.59 < 0.001
GM/WM density ratio 1.26 ± 0.31 1.36 ± 0.16 < 0.001
Brainstem
Midbrain 30.54 ± 5.37 39.53 ± 9.14 < 0.001
Pons 31.22 ± 6.29 36.80 ± 5.98 < 0.001
Medulla oblongata 27.82 ± 9.58 38.76 ± 6.70 < 0.001
Data refer to mean value ± standard deviation. BG – basal ganglia, GM – grey matter, WM – white matter
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GM/WM density ratio of each level except for BG were 
found to be significantly lower in BD patients compared 
to the control group (p = 0.019 for HC­WM, p < 0.001 
for other areas). A cut­off value of GM/WM density ratio 
at the HC level was determined as 1.25 with a sensitivity 
of 90% and specificity of 73% for the prediction of BD. 
The sensitivity increased to 98% when CTP was used as 
an adjunct to density measurement.
Diffuse decrease in the cortical GM density has been 
defined as one of the CT findings of cerebral hypoperfu­
sion [21]. This appearance could be explained by cytotoxic 
oedema, which occurs as a result of the disruption of the 
sodium­potassium pump in anoxic cells and is known to be 
more prominent in GM due to the high metabolic demand 
[21]. In our study, this finding was assessed by perform­
ing various HU measurements from brain parenchyma in 
brain­dead patients, and the GM density was found to be 
significantly low when compared to the control group at 
each level. Low density values in GM have also been shown 
in previous studies consisting of comatose or brain­dead 
patient groups [8,11,17,19]. However, there is a discrepancy 
between studies regarding the results of WM density. In 
many studies performed in comatose patients after cardiac 
arrest, WM values were not found to be statistically sig­
nificant [14­17,22,23], whereas an increase in WM density 
compared to the control group was recorded in one study 
[11]. In our study, WM density was found to be signifi­
cantly lower in patients with BD, which was also shown by 
Vigneron et al. [19]. This situation could be explained by 
the difference in characteristics of patient populations and 
possibly the timing of the CT scan.
Quantitative measurements on CT imaging have been 
commonly studied to evaluate the distinction of vegeta­
tive state­death or good­poor neurologic outcome after 
cardiac arrest [8,11,12,17,23,24]. The first study of the use 
of GM/WM density ratio to assess the prognosis of coma­
tose patients after cardiac arrest was conducted by Torbey 
et al., in which the cut­off ratio was found to be 1.18 [11]. 
They indicated that values below this rate at the BG level 
were 100% predictive for death. In a meta­analysis involv­
ing 1150 patients from 10 studies, it was concluded that 
the GM/WM ratio had a high prognostic value in predict­
ing a poor neurologic outcome in patients after cardiac ar­
rest in the early period [25]. They reported that the cut­off 
values of seven studies at BG level were between 1.10 and 
1.24 [25]. In a study consisting of 15 brain­dead patients 
conducted by Vigneron et al., the cut­off value was deter­
mined as 1.21 at basal ganglion level, but in their study the 
sensitivity was not stated [19]. In our study, with a greater 
patient population, it was found that values below 1.25 in 
the GM/WM ratio at the HC level could be useful in pre­
dicting BD with high sensitivity. Also, unlike in the above 
Figure 4. A 54-year-old female patient clinically diagnosed as brain death. A) Unenhanced axial computed tomography image at high convexity level shows 
diffuse cerebral edema and loss of differentiation between gray and white matter. The attenuation values of grey matter (GM) and white matter (WM) were 
37 and 34 HU, respectively. GM/WM ratio was found as 1.08 which was below 1.25. (The regions where regions of interests are placed in gray and white 
matter were shown schematically with a white circle.) B) Cerebral blood volume map demonstrates the absence of cerebral perfusion which was compatible 
with brain death. (Cerebral blood flow and mean transit time maps not shown) 
Figure 3. Receiver operating curve analysis of grey matter/white matter 
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study, the density measurement at this level was found 
to have very close sensitivity values (90%) compared to 
CTP (93%) obtained in the same session. We suggest that 
measurements from this localisation could provide more 
reliable results in such a heterogeneous patient population 
with comorbid diseases and/or intracranial haemorrhage.
There are a number of studies that have investigated 
the contribution of CTP to CTA in confirmation of BD 
[2­4,26]. To our knowledge, this is the first study on evalu­
ation of density measurements on unenhanced CT with 
the added value of CTP in predicting BD. According to 
the pattern of BD proposed by Palmer and Bader, a lack 
of cerebral blood flow is seen when intracranial pressure 
exceeds mean arterial pressure [1]. As a result, cerebral 
circulatory arrest leads to cytotoxic injury and subsequent 
irreversible neuronal damage. For determination of the 
absence of cerebral perfusion, CTP could be a suitable 
method in patients clinically diagnosed as BD. While the 
sensitivity of CTP was found to be 93% in our study, this 
value reached 98% with the addition of the GM/WM den­
sity ratio from the HC level. According to this result, we 
think that BD could be predicted with 98% sensitivity by 
performing a combined protocol of unenhanced CT scan 
and CTP with a 40 ml contrast media without CTA. How­
ever, this result needs to be supported by further studies 
involving more BD patients and a separate group of coma 
and intensive care patients as the control group.
Our study has several limitations. First, the timing 
of CT scan was not the same for all brain­dead patients. 
This condition might affect the attenuation of brain pa­
renchyma among patients. However, in a study conduct­
ed by Metter et al., no significant relationship was found 
between the time from arrest to CT and the attenuation 
values in patients with cardiac arrest [8]. In another study, 
Scheel et al. reported that there was a gradual decrease in 
the median GM/WM density ratio value in CTs taken at six 
hours, 6­24 hours, and 24 hours, but there was no statisti­
cally significant difference between the three groups [23]. 
Contrarily, Wu et al. found a significant decrease in puta­
men density on CT taken at 24­72 hours compared to the 
first 24 hours [24]. However, as far as we know, there is no 
study on the alteration of attenuation over time after the 
diagnosis of BD. Second, in some patients, haematoma, 
herniation, shift, and artifacts passing through brainstem 
level caused difficulty in measuring the density. In order 
to determine the effect of this limitation on the results, 
interobserver reliability was evaluated and found to be in 
good or excellent agreement, except for cerebellum GM, 
midbrain, and pons levels, which is possibly due to the 
beam hardening artifacts passing through the posterior 
fossa. Third, CTP was performed after CTA because CTP 
has not yet been proven as a valid method in BD diagno­
sis. Contrast stasis in vessels may potentially create a limi­
tation for the CTP. We attempted to minimise this limita­
tion by allowing a waiting period of 10­15 minutes after 
CTA; a longer waiting period could not be performed 
because this patient group had to be followed under in­
tensive care conditions.
Conclusions
The GM/WM density ratio at the HC level on unen­
hanced CT scan may be a useful finding to predict BD. 
The addition of CTP promotes this prediction by increas­
ing the sensitivity. The combination of unenhanced CT and 
CTP might be reasonably acceptable by using lower amount 
of intravenous contrast media for BD patients who are po­
tential candidates as donors for organ transplantation.
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Table 2. Inter-rater agreement results in evaluating the parenchymal density measurement
Level Parenchymal density measurement
Reader 1 Reader 2 ICC (CI)
BG-GM 32.13 ± 4.27 30.69 ± 3.67 0.869 (0.692-0.933)
BG-WM 27.29 ± 3.13 28.30 ± 3.17 0.817 (0.674-0.892)
CS-GM 33.26 ± 4.89 34.06 ± 4.70 0.737 (0.587-0.832)
CS-WM 29.33 ± 3.84 30.07 ± 3.57 0.894 (0.824-0.935)
HC-GM 35.67 ± 5.24 34.37 ± 4.58 0.808 (0.685-0.881)
HC-WM 32.60 ± 4.63 30.77 ± 4.02 0.830 (0.600-0.914)
Cerebellum-GM 39.76 ± 7.57 36.26 ± 4.50 0.522 (0.211-0.705)
Cerebellum-WM 32.09 ± 5.28 30.96 ± 3.56 0.669 (0.481-0.789)
Midbrain 30.55 ± 5.37 30.19 ± 4.58 0.738 (0.588-0.834)
Pons 31.22 ± 6.29 30.75±5.37 0.573 (0.325-0.729)
Medulla oblongata 27.83 ± 9.58 30.45 ± 5.62 0.569 (0.323-0.726)
Data of reader 1 and reader 2 refer to mean value ± standard deviation. CI – 95% confidence interval, ICC – interclass correlation coefficient, BG – basal ganglia, CS – centrum semiovale, 
HC – high convexity, GM – grey matter, WM – white matter 
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